CCL2 and neoplasm: Studies have shown that inhibition of CCL2 reduces bone marrow monocyte infiltration and TAM polarization, thereby slowing down tumor growth in various cancers, such as lung cancer, bladder cancer, and hepatocellular carcinoma (HCC) [83].